State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$3.42B |
| 2 |
Cigna
CI
|
+$1.25B |
| 3 |
CVS Health
CVS
|
+$1.25B |
| 4 |
Marathon Petroleum
MPC
|
+$805M |
| 5 |
Diamondback Energy
FANG
|
+$589M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$3.86B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.31B |
| 3 |
PX
Praxair Inc
PX
|
+$2.1B |
| 4 |
Apple
AAPL
|
+$1.38B |
| 5 |
ANDV
Andeavor
ANDV
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.79% |
| 2 | Technology | 15.42% |
| 3 | Healthcare | 14.78% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Ericsson
ERIC
$33.7B
| $760K | ﹤0.01% |
+85,720
| New | +$745K |
|
3277
Asure Software
ASUR
$254M
| $759K | ﹤0.01% |
149,471
-211
| -0.1% | -$1.74K |
|
|
VAPO
3278
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $759K | ﹤0.01% |
+4,758
| New | +$686K |
|
3279
Cogent Biosciences
COGT
$7.32B
| $757K | ﹤0.01% |
43,039
+26,079
| +154% | +$772K |
|
|
TOUR
3280
Tuniu
TOUR
$54.5M
| $756K | ﹤0.01% |
15,551
+582
| +4% | +$35.3K |
|
|
YARW
3281
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
| $756K | ﹤0.01% |
51
+13
| +34% | +$291K |
|
3282
CRISPR Therapeutics
CRSP
$5.23B
| $753K | ﹤0.01% |
26,353
-1,117
| -4% | -$38.8K |
|
3283
Corvus Pharmaceuticals
CRVS
$1.17B
| $748K | ﹤0.01% |
203,776
+20,552
| +11% | +$140K |
|
3284
ADMA Biologics
ADMA
$2.07B
| $743K | ﹤0.01% |
311,085
+24,639
| +9% | +$122K |
|
3285
Globalstar
GSAT
$10.8B
| $737K | ﹤0.01% |
76,764
-2,009
| -3% | -$12K |
|
|
DZSI
3286
DELISTED
DZS Inc. Common Stock
DZSI
| $731K | ﹤0.01% |
52,586
+5,032
| +11% | +$68.1K |
|
3287
Smart Sand
SND
$193M
| $722K | ﹤0.01% |
325,332
-85,399
| -21% | -$269K |
|
3288
Star Bulk Carriers
SBLK
$3.15B
| $720K | ﹤0.01% |
78,721
+3,221
| +4% | +$35.2K |
|
|
MRSN
3289
DELISTED
Mersana Therapeutics
MRSN
| $717K | ﹤0.01% |
7,032
-336
| -5% | -$53.2K |
|
3290
Barclays
BCS
$94.5B
| $709K | ﹤0.01% |
+98,403
| New | +$793K |
|
|
AKAO
3291
DELISTED
Achaogen Inc
AKAO
| $706K | ﹤0.01% |
574,119
-63,413
| -10% | -$169K |
|
|
NTP
3292
DELISTED
Nam Tai Property Inc.
NTP
| $700K | ﹤0.01% |
80,697
+12,848
| +19% | +$119K |
|
3293
Serina Therapeutics
SER
$32.1M
| $699K | ﹤0.01% |
+6,647
| New | +$845K |
|
3294
Philips
PHG
$25.9B
| $697K | ﹤0.01% |
25,561
-32,368
| -56% | -$956K |
|
3295
Canadian National Railway
CNI
$77B
| $692K | ﹤0.01% |
+9,331
| New | +$773K |
|
3296
State Street Multi-Asset Real Return ETF
RLY
$1.26B
| $691K | ﹤0.01% |
30,389
-577
| -2% | -$14.3K |
|
3297
CRH
CRH
$65.8B
| $688K | ﹤0.01% |
26,105
-13,200
| -34% | -$374K |
|
|
HIMX
3298
Himax Technologies
HIMX
$2.47B
| $687K | ﹤0.01% |
200,237
+21,352
| +12% | +$101K |
|
3299
Cartesian Therapeutics
RNAC
$237M
| $678K | ﹤0.01% |
8,501
+4
| +0% | +$913 |
|
3300
ProQR Therapeutics
PRQR
$258M
| $677K | ﹤0.01% |
+42,923
| New | +$788K |
|
Similar funds
State Street's Q4 2018 Portfolio in Review
As of Q4 2018, State Street held 3,872 positions worth $1.1T, down 16% from $1.3T the previous quarter. Its ten largest holdings account for 17% of the portfolio.
State Street's Q4 2018 filing shows 102 new, 1,442 increased, 2,108 reduced and 110 closed positions. Its largest new stake was Linde: 21,625,224 shares worth $3.37B. The largest sale was Aetna Inc, an estimated $3.86B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
- State Street's largest Q4 2018 buy was Linde: 21,625,224 shares worth $3.37B.
- State Street added most to Cigna in Q4 2018, an estimated $1.25B increase.
- State Street's biggest Q4 2018 reduction was Apple, cutting an estimated $1.38B.
- State Street fully exited Aetna Inc in Q4 2018, selling an estimated $3.86B.
- State Street's ten largest holdings make up 17% of its $1.1T portfolio in Q4 2018.
- State Street opened 102 new positions and closed 110 in Q4 2018.
- State Street's portfolio value fell 16% quarter-over-quarter to $1.1T.
Based on State Street's 13F filing for Q4 2018, filed 12 Feb 2019.